世界の鳥インフルエンザワクチン市場2025

◆英語タイトル:Global Avian Influenza Vaccine Market Research Report—Forecast till 2025
◆商品コード:MRF20OT004
◆発行会社(リサーチ会社):Market Research Future
◆発行日:2020年2月11日
◆ページ数:101
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(印刷不可、Online Access)USD4,450 ⇒換算¥480,600見積依頼/購入/質問フォーム
Enterprisewide Price(印刷可)USD6,250 ⇒換算¥675,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarket Research Future社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Market Research Future社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、鳥インフルエンザワクチンの世界市場について調査・分析し、エグゼクティブサマリー、イントロダクション、調査手法、市場動向、市場要因分析、ストレーン別市場規模(H5、H7、H9)、用途別市場規模(鳥、ターキー、ガチョウ・カモ)、地域別市場規模、競争状況、企業概要などの項目を掲載しています。
・エグゼクティブサマリー
・イントロダクション
・調査手法
・市場動向
・市場要因分析
・鳥インフルエンザワクチンの世界市場規模:ストレーン別(H5、H7、H9)
・鳥インフルエンザワクチンの世界市場規模:用途別(鳥、ターキー、ガチョウ・カモ)
・鳥インフルエンザワクチンの世界市場規模:地域別
・競争状況
・企業概要
【レポートの概要】

Global Avian Influenza Vaccine Market Research Report—Forecast till 2025

[Market Snapshot]
Global Avian Influenza Vaccine Market is evaluated to reach a CAGR of 7.25% to reach USD 735.22 Million during the review period. Avian influenza, also referred to as bird flu, is a virus that infects birds such as ducks and geese and it can spread to domestic poultry, such as chickens and turkeys. There are different strains of avian influenza, causing infection however; H5V1 is the most common virus strain contaminating poultry animals, birds, and humans.
The rising strategic reconciliation is estimated to drive market growth during the forecast period. However, in February 2018, the NC State College of Veterinary Medicine and Ceva Santé Animale, an animal health company, based in France, worked together on a distance learning project presenting certification in poultry health management for veterinarians in Latin America. Furthermore, the growing public & private initiatives by the government as well as non-government organizations for research & development are also evaluated to propel the market growth.

[Market Segmentation]
The Global Avian Influenza Vaccine Market has been categorized based on strain and application. The market, by strain segment, has been further classified into H5, H7, and H9. By application type, the avian influenza vaccine market has been divided into the chicken, turkey, and goose & duck.

[Regional Analysis]
The geographical market of the Global Avian Influenza Vaccine Market, by region, has been segregated into the APAC & Middle East, Europe, Americas, and Africa.

The APAC & Middle East is anticipated to lead the global avian influenza vaccine market. The regional market is attributed to the rising production of poultry birds and the rise in avian influenza outbreaks. The key market driving factors are various government initiatives for rapid and effective response efforts to emergent zoonotic influenza viruses.
The European market for the avian influenza vaccine is anticipated to be the second-largest during the study period. The increasing dependence on poultry as the key source of protein in the diet is estimated to expand the growth of the regional market.
Americas are likely to register significant market growth due to the increasing meat & poultry industry, the rising investment in animal health, and the existence of a large number of veterinary hospitals in the region.

[Major Players]
The Prominent Players in the Global Avian Influenza Vaccine Market are Boehringer Ingelheim International GmbH (Germany), Guangdong Wenshi Dahuanong Biotechnology Co., Ltd (China), Ceva (US), Yebio Bioengineering Co., Ltd (China), Zoetis (US), FATRO S.P.A. (Italy), CAVAC (South Korea), Tianjin Ringpu Bio-Technology Co., Ltd (China), PT Japfa Comfeed Indonesia Tbk (Indonesia), Chengdu Tech-bank Biological Products Co., Ltd (China), Merck Animal Health (US), Medion (Indonesia), Avimex Animal Health (Mexico), JOVAC (Jordan), and QYH BIOTECH COMPANY LIMITED (China). Some of the key strategies followed by players operating in the global avian influenza vaccine market were collaborations, acquisition, product approval & launch, and expansion.

[COVID 19 Impacts]
We are continuously tracking the impact of COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations and many other useful insights.

【レポートの目次】

TABLE OF CONTENT
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 14

2.2 RESEARCH OBJECTIVE 14

2.3 LIST OF ASSUMPTIONS 14

3 RESEARCH METHODOLOGY
3.1 OVERVIEW 16

3.2 DATA MINING 16

3.3 SECONDARY RESEARCH 17

3.4 PRIMARY RESEARCH 17

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 19

3.5 FORECASTING TECHNIQUES 19

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20

3.6.1 BOTTOM-UP APPROACH 21

3.6.2 TOP-DOWN APPROACH 22

3.7 DATA TRIANGULATION 23

3.8 VALIDATION 23

4 MARKET DYNAMICS
4.1 OVERVIEW 24

4.2 DRIVERS 25

4.2.1 INCREASING STRATEGIC AGREEMENTS 25

4.2.2 INCREASING PUBLIC AND PRIVATE INITIATIVES FOR RESEARCH AND DEVELOPMENT 25

4.3 RESTRAINTS 26

4.3.1 UNAFFORDABILITY OF PROVIDING VETERINARY SERVICES IN UNDEVELOPED AND DEVELOPING ECONOMIES 26

4.4 OPPORTUNITIES 27

4.4.1 INCREASING NUMBER OF CLINICAL TRIAL CANDIDATES 27

5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS 28

5.1.1 R&D & DESIGNING 29

5.1.2 MANUFACTURING 29

5.1.3 DISTRIBUTION, MARKETING, AND SALES 29

5.2 PORTER’S FIVE FORCES MODEL 30

5.2.1 THREAT OF NEW ENTRANTS 30

5.2.2 BARGAINING POWER OF SUPPLIERS 31

5.2.3 BARGAINING POWER OF BUYERS 31

5.2.4 THREAT OF SUBSTITUTES 31

5.2.5 INTENSITY OF RIVALRY 31

6 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY STRAIN
6.1 OVERVIEW 32

6.2 H5 33

6.3 H7 34

6.4 H9 34

7 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION
7.1 OVERVIEW 35

7.2 CHICKEN 36

7.3 TURKEY 37

7.4 GOOSE & DUCK 37

8 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY REGION
8.1 OVERVIEW 39

8.2 APAC & MIDDLE EAST 41

8.2.1 CHINA 43

8.2.2 PHILIPPINES 44

8.2.3 VIETNAM 44

8.2.4 INDIA 45

8.2.5 BANGLADESH 46

8.2.6 CAMBODIA 46

8.2.7 INDONESIA 47

8.2.8 IRAN 48

8.2.9 THAILAND 48

8.2.10 PAKISTAN 49

8.2.11 REST OF APAC & MIDDLE EAST 50

8.3 EUROPE 51

8.3.1 GERMANY 53

8.3.2 BULGARIA 53

8.3.3 POLAND 54

8.3.4 HUNGARY 55

8.3.5 UKRAINE 55

8.3.6 CZECH REPUBLIC 56

8.3.7 REST OF EUROPE 57

8.4 AMERICAS 58

8.4.1 US 60

8.4.2 BRAZIL 60

8.4.3 MEXICO 61

8.4.4 ARGENTINA 62

8.4.5 COLUMBIA 62

8.4.6 REST OF THE AMERICAS 63

8.5 AFRICA 64

8.5.1 SOUTH AFRICA 65

8.5.2 NIGERIA 66

8.5.3 GHANA 67

8.5.4 CAMEROON 67

8.5.5 REST OF AFRICA 68

9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW 69

9.2 COMPETITIVE ANALYSIS 69

10 COMPANY PROFILES
10.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 70

10.1.1 COMPANY OVERVIEW 70

10.1.2 FINANCIAL OVERVIEW 71

10.1.3 PRODUCTS/SERVICES OFFERED 71

10.1.4 KEY DEVELOPMENTS 72

10.2 GUANGDONG WENSHI DAHUANONG BIOTECHNOLOGY CO., LTD 73

10.2.1 COMPANY OVERVIEW 73

10.2.2 FINANCIAL OVERVIEW 73

10.2.3 PRODUCTS/SERVICES OFFERED 73

10.2.4 KEY DEVELOPMENTS 73

10.3 CEVA 74

10.3.1 COMPANY OVERVIEW 74

10.3.2 FINANCIAL OVERVIEW 74

10.3.3 PRODUCTS/SERVICES OFFERED 75

10.3.4 KEY DEVELOPMENTS 75

10.4 YEBIO BIOENGINEERING CO., LTD 76

10.4.1 COMPANY OVERVIEW 76

10.4.2 FINANCIAL OVERVIEW 76

10.4.3 PRODUCTS/SERVICES OFFERED 76

10.4.4 KEY DEVELOPMENTS 76

10.5 ZOETIS 77

10.5.1 COMPANY OVERVIEW 77

10.5.2 FINANCIAL OVERVIEW 77

10.5.3 PRODUCTS/SERVICES OFFERED 78

10.5.4 KEY DEVELOPMENTS 78

10.6 FATRO S.P.A. 79

10.6.1 COMPANY OVERVIEW 79

10.6.2 FINANCIAL OVERVIEW 79

10.6.3 PRODUCTS/SERVICES OFFERED 79

10.6.4 KEY DEVELOPMENTS 79

10.7 CAVAC 80

10.7.1 COMPANY OVERVIEW 80

10.7.2 FINANCIAL OVERVIEW 80

10.7.3 PRODUCTS/SERVICES OFFERED 80

10.7.4 KEY DEVELOPMENTS 80

10.8 TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD 81

10.8.1 COMPANY OVERVIEW 81

10.8.2 FINANCIAL OVERVIEW 81

10.8.3 PRODUCTS/SERVICES OFFERED 81

10.8.4 KEY DEVELOPMENTS 81

10.9 PT JAPFA COMFEED INDONESIA TBK 82

10.9.1 COMPANY OVERVIEW 82

10.9.2 FINANCIAL OVERVIEW 82

10.9.3 PRODUCTS/SERVICES OFFERED 83

10.9.4 KEY DEVELOPMENTS 83

10.10 CHENGDU TECH-BANK BIOLOGICAL PRODUCTS CO., LTD 84

10.10.1 COMPANY OVERVIEW 84

10.10.2 FINANCIAL OVERVIEW 84

10.10.3 PRODUCTS/SERVICES OFFERED 84

10.10.4 KEY DEVELOPMENTS 84

10.11 MERCK ANIMAL HEALTH 85

10.11.1 COMPANY OVERVIEW 85

10.11.2 FINANCIAL OVERVIEW 85

10.11.3 PRODUCTS/SERVICES OFFERED 86

10.11.4 KEY DEVELOPMENTS 86

10.12 MEDION 87

10.12.1 COMPANY OVERVIEW 87

10.12.2 FINANCIAL OVERVIEW 87

10.12.3 PRODUCTS/SERVICES OFFERED 87

10.12.4 KEY DEVELOPMENTS 87

10.13 AVIMEX ANIMAL HEALTH 88

10.13.1 COMPANY OVERVIEW 88

10.13.2 FINANCIAL OVERVIEW 88

10.13.3 PRODUCTS/SERVICES OFFERED 88

10.13.4 KEY DEVELOPMENTS 88

10.14 JOVAC 89

10.14.1 COMPANY OVERVIEW 89

10.14.2 FINANCIAL OVERVIEW 89

10.14.3 PRODUCTS/SERVICES OFFERED 89

10.14.4 KEY DEVELOPMENTS 89

10.15 QYH BIOTECH COMPANY LIMITED 90

10.15.1 COMPANY OVERVIEW 90

10.15.2 FINANCIAL OVERVIEW 90

10.15.3 PRODUCTS/SERVICES OFFERED 90

10.15.4 KEY DEVELOPMENTS 90

11 APPENDIX
11.1 REFERENCES 91

11.2 RELATED REPORTS 91

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS 14

TABLE 2 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 32

TABLE 3 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR H5, BY REGION, 2016–2025 (USD MILLION) 33

TABLE 4 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR H7, BY REGION, 2016–2025 (USD MILLION) 34

TABLE 5 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR H9, BY REGION, 2016–2025 (USD MILLION) 34

TABLE 6 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 35

TABLE 7 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR CHICKEN, BY REGION, 2016–2025 (USD MILLION) 36

TABLE 8 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR TURKEY, BY REGION, 2016–2025 (USD MILLION) 37

TABLE 9 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR GOOSE, BY REGION, 2016–2025 (USD MILLION) 38

TABLE 10 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR DUCK, BY REGION, 2016–2025 (USD MILLION) 38

TABLE 11 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY REGION, 2016–2025 (USD MILLION) 39

TABLE 12 APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 42

TABLE 13 APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 42

TABLE 14 APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 43

TABLE 15 CHINA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 43

TABLE 16 CHINA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 43

TABLE 17 PHILIPPINES: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 44

TABLE 18 PHILIPPINES: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 44

TABLE 19 VIETNAM: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 44

TABLE 20 VIETNAM: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 45

TABLE 21 INDIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 45

TABLE 22 INDIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 45

TABLE 23 BANGLADESH: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 46

TABLE 24 BANGLADESH: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 46

TABLE 25 CAMBODIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 46

TABLE 26 CAMBODIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 47

TABLE 27 INDONESIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 47

TABLE 28 INDONESIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 47

TABLE 29 IRAN: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 48

TABLE 30 IRAN: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 48

TABLE 31 THAILAND: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 48

TABLE 32 THAILAND: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 49

TABLE 33 PAKISTAN: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 49

TABLE 34 PAKISTAN: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 49

TABLE 35 REST OF APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 50

TABLE 36 REST OF APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 50

TABLE 37 EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 52

TABLE 38 EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 52

TABLE 39 EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 52

TABLE 40 GERMANY: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 53

TABLE 41 GERMANY: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 53

TABLE 42 BULGARIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 53

TABLE 43 BULGARIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 54

TABLE 44 POLAND: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 54

TABLE 45 POLAND: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 54

TABLE 46 HUNGARY: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 55

TABLE 47 HUNGARY: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 55

TABLE 48 UKRAINE: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 55

TABLE 49 UKRAINE: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 56

TABLE 50 CZECH REPUBLIC: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 56

TABLE 51 CZECH REPUBLIC: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 56

TABLE 52 REST OF EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 57

TABLE 53 REST OF EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 57

TABLE 54 AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 59

TABLE 55 AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 59

TABLE 56 AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 59

TABLE 57 US: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 60

TABLE 58 US: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 60

TABLE 59 BRAZIL: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 60

TABLE 60 BRAZIL: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 61

TABLE 61 MEXICO: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 61

TABLE 62 MEXICO: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 61

TABLE 63 ARGENTINA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 62

TABLE 64 ARGENTINA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 62

TABLE 65 COLUMBIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 62

TABLE 66 COLUMBIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 63

TABLE 67 REST OF THE AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 63

TABLE 68 REST OF THE AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 63

TABLE 69 AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 64

TABLE 70 AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 65

TABLE 71 AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 65

TABLE 72 SOUTH AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 65

TABLE 73 SOUTH AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 66

TABLE 74 NIGERIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 66

TABLE 75 NIGERIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 66

TABLE 76 GHANA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 67

TABLE 77 GHANA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 67

TABLE 78 CAMEROON: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 67

TABLE 79 CAMEROON: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 68

TABLE 80 REST OF AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 68

TABLE 81 REST OF AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 68

TABLE 82 MAJOR MANUFACTURERS: GLOBAL AVIAN INFLUENZA VACCINE MARKET 69

TABLE 83 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS/SERVICES OFFERED 71

TABLE 84 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY DEVELOPMENTS 72

TABLE 85 GUANGDONG WENSHI DAHUANONG BIOTECHNOLOGY CO., LTD: PRODUCTS/SERVICES OFFERED 73

TABLE 86 CEVA: PRODUCTS/SERVICES OFFERED 75

TABLE 87 CEVA: KEY DEVELOPMENTS 75

TABLE 88 YEBIO BIOENGINEERING CO., LTD: PRODUCTS/SERVICES OFFERED 76

TABLE 89 ZOETIS: PRODUCTS/SERVICES OFFERED 78

TABLE 90 ZOETIS: KEY DEVELOPMENTS 78

TABLE 91 FATRO S.P.A.: PRODUCTS/SERVICES OFFERED 79

TABLE 92 CAVAC: PRODUCTS/SERVICES OFFERED 80

TABLE 93 TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD: PRODUCTS/SERVICES OFFERED 81

TABLE 94 PT JAPFA COMFEED INDONESIA TBK: PRODUCTS/SERVICES OFFERED 83

TABLE 95 CHENGDU TECH-BANK BIOLOGICAL PRODUCTS CO., LTD: PRODUCTS/SERVICES OFFERED 84

TABLE 96 MERCK ANIMAL HEALTH: PRODUCTS/SERVICES OFFERED 86

TABLE 97 MERCK ANIMAL HEALTH: KEY DEVELOPMENTS 86

TABLE 98 MEDION: PRODUCTS/SERVICES OFFERED 87

TABLE 99 AVIMEX ANIMAL HEALTH: PRODUCTS/SERVICES OFFERED 88

TABLE 100 JOVAC: PRODUCTS/SERVICES OFFERED 89

TABLE 101 QYH BIOTECH COMPANY LIMITED: PRODUCTS/SERVICES OFFERED 90


LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS 13

FIGURE 2 GLOBAL AVIAN INFLUENZA VACCINE MARKET STRUCTURE 15

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 21

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL AVIAN INFLUENZA VACCINE MARKET 24

FIGURE 5 DRIVER IMPACT ANALYSIS 26

FIGURE 6 RESTRAINT IMPACT ANALYSIS 26

FIGURE 7 SUPPLY CHAIN ANALYSIS 28

FIGURE 8 PORTER’S FIVE FORCES MODEL 30

FIGURE 9 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2018 (%) 32

FIGURE 10 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2018 & 2025 (USD MILLION) 33

FIGURE 11 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2018 (%) 35

FIGURE 12 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2018 & 2025 (USD MILLION) 36

FIGURE 13 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY REGION, 2018 (%) 39

FIGURE 14 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY REGION, 2018 & 2025 (USD MILLION) 40

FIGURE 15 APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2018 (%) 41

FIGURE 16 EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2018 (%) 51

FIGURE 17 AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2018 (%) 58

FIGURE 18 AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2018 (%) 64

FIGURE 19 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: FINANCIAL OVERVIEW SNAPSHOT 71

FIGURE 20 CEVA: FINANCIAL OVERVIEW SNAPSHOT 74

FIGURE 21 ZOETIS: FINANCIAL OVERVIEW SNAPSHOT 77

FIGURE 22 TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD: FINANCIAL OVERVIEW SNAPSHOT 81

FIGURE 23 PT JAPFA COMFEED INDONESIA TBK: FINANCIAL OVERVIEW SNAPSHOT 82

FIGURE 24 MERCK ANIMAL HEALTH: FINANCIAL OVERVIEW SNAPSHOT 85



















【掲載企業】

Boehringer Ingelheim International GmbH (Germany), Guangdong Wenshi Dahuanong Biotechnology Co., Ltd (China), Ceva (US), Yebio Bioengineering Co., Ltd (China), Zoetis (US), FATRO S.P.A. (Italy), CAVAC (South Korea), Tianjin Ringpu Bio-Technology Co., Ltd (China), PT Japfa Comfeed Indonesia Tbk (Indonesia), Chengdu Tech-bank Biological Products Co., Ltd (China), Merck Animal Health (US), Medion (Indonesia), Avimex Animal Health (Mexico), JOVAC (Jordan), and QYH BIOTECH COMPANY LIMITED (China). Some of the key strategies followed by players operating in the global avian influenza vaccine market were collaborations, acquisition, product approval & launch, and expansion

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の鳥インフルエンザワクチン市場2025]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆